aluates Reports

$ 0.0

Automative

COVID-19 Vaccines & Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-37Q14207

Global COVID 19 Vaccines Therapeutics Market Research Report 2023

BUY CHAPTERS

COVID-19 Vaccines & Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-37Q14207

Report

October 2024

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Moderna Therapeutics

Astrazeneca plc

Janssen

Novavax Inc

Gilead Sciences

Eli Lilly and Company

COVID-19 Vaccines & Therapeutics - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

COVID-19 Vaccines & Therapeutics - Market

COVID-19 Vaccines & Therapeutics are medical products developed to prevent or treat infections caused by the novel coronavirus SARS-CoV-2. Vaccines provide immunity against the virus, while therapeutics aim to alleviate symptoms and reduce the severity of the disease. These products play a critical role in managing the COVID-19 pandemic.

The global market for COVID-19 Vaccines & Therapeutics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for COVID-19 Vaccines & Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of COVID-19 Vaccines & Therapeutics by region & country, by Type, and by Application.

The COVID-19 Vaccines & Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Vaccines & Therapeutics.

Market Segmentation

Scope of COVID-19 Vaccines & Therapeutics - Market Report

Report Metric	Details
Report Name	COVID-19 Vaccines & Therapeutics - Market
CAGR	5%
Segment by Type:	COVID-19 Vaccines COVID-19 Therapeutics
Segment by Application	Children Adult
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Moderna Therapeutics, AstraZeneca, Janssen, Novavax, Gilead Sciences, Eli Lilly and Company
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of COVID-19 Vaccines & Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of COVID-19 Vaccines & Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of COVID-19 Vaccines & Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the COVID-19 Vaccines & Therapeutics - Market report?

Ans: The main players in the COVID-19 Vaccines & Therapeutics - Market are Pfizer, Moderna Therapeutics, AstraZeneca, Janssen, Novavax, Gilead Sciences, Eli Lilly and Company

What are the Application segmentation covered in the COVID-19 Vaccines & Therapeutics - Market report?

Ans: The Applications covered in the COVID-19 Vaccines & Therapeutics - Market report are Children, Adult

What are the Type segmentation covered in the COVID-19 Vaccines & Therapeutics - Market report?

Ans: The Types covered in the COVID-19 Vaccines & Therapeutics - Market report are COVID-19 Vaccines, COVID-19 Therapeutics

Recommended Reports

COVID-19 Therapeutics

COVID-19 Vaccines

COVID-19 Diagnostics

1 Market Overview

1.1 COVID-19 Vaccines & Therapeutics Product Introduction

1.2 Global COVID-19 Vaccines & Therapeutics Market Size Forecast

1.3 COVID-19 Vaccines & Therapeutics Market Trends & Drivers

1.3.1 COVID-19 Vaccines & Therapeutics Industry Trends

1.3.2 COVID-19 Vaccines & Therapeutics Market Drivers & Opportunity

1.3.3 COVID-19 Vaccines & Therapeutics Market Challenges

1.3.4 COVID-19 Vaccines & Therapeutics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global COVID-19 Vaccines & Therapeutics Players Revenue Ranking (2023)

2.2 Global COVID-19 Vaccines & Therapeutics Revenue by Company (2019-2024)

2.3 Key Companies COVID-19 Vaccines & Therapeutics Manufacturing Base Distribution and Headquarters

2.4 Key Companies COVID-19 Vaccines & Therapeutics Product Offered

2.5 Key Companies Time to Begin Mass Production of COVID-19 Vaccines & Therapeutics

2.6 COVID-19 Vaccines & Therapeutics Market Competitive Analysis

2.6.1 COVID-19 Vaccines & Therapeutics Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by COVID-19 Vaccines & Therapeutics Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Vaccines & Therapeutics as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 COVID-19 Vaccines

3.1.2 COVID-19 Therapeutics

3.2 Global COVID-19 Vaccines & Therapeutics Sales Value by Type

3.2.1 Global COVID-19 Vaccines & Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global COVID-19 Vaccines & Therapeutics Sales Value, by Type (2019-2030)

3.2.3 Global COVID-19 Vaccines & Therapeutics Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Children

4.1.2 Adult

4.2 Global COVID-19 Vaccines & Therapeutics Sales Value by Application

4.2.1 Global COVID-19 Vaccines & Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global COVID-19 Vaccines & Therapeutics Sales Value, by Application (2019-2030)

4.2.3 Global COVID-19 Vaccines & Therapeutics Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global COVID-19 Vaccines & Therapeutics Sales Value by Region

5.1.1 Global COVID-19 Vaccines & Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global COVID-19 Vaccines & Therapeutics Sales Value by Region (2019-2024)

5.1.3 Global COVID-19 Vaccines & Therapeutics Sales Value by Region (2025-2030)

5.1.4 Global COVID-19 Vaccines & Therapeutics Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America COVID-19 Vaccines & Therapeutics Sales Value, 2019-2030

5.2.2 North America COVID-19 Vaccines & Therapeutics Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe COVID-19 Vaccines & Therapeutics Sales Value, 2019-2030

5.3.2 Europe COVID-19 Vaccines & Therapeutics Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific COVID-19 Vaccines & Therapeutics Sales Value, 2019-2030

5.4.2 Asia Pacific COVID-19 Vaccines & Therapeutics Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America COVID-19 Vaccines & Therapeutics Sales Value, 2019-2030

5.5.2 South America COVID-19 Vaccines & Therapeutics Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa COVID-19 Vaccines & Therapeutics Sales Value, 2019-2030

5.6.2 Middle East & Africa COVID-19 Vaccines & Therapeutics Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions COVID-19 Vaccines & Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions COVID-19 Vaccines & Therapeutics Sales Value

6.3 United States

6.3.1 United States COVID-19 Vaccines & Therapeutics Sales Value, 2019-2030

6.3.2 United States COVID-19 Vaccines & Therapeutics Sales Value by Type (%), 2023 VS 2030

6.3.3 United States COVID-19 Vaccines & Therapeutics Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe COVID-19 Vaccines & Therapeutics Sales Value, 2019-2030

6.4.2 Europe COVID-19 Vaccines & Therapeutics Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe COVID-19 Vaccines & Therapeutics Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China COVID-19 Vaccines & Therapeutics Sales Value, 2019-2030

6.5.2 China COVID-19 Vaccines & Therapeutics Sales Value by Type (%), 2023 VS 2030

6.5.3 China COVID-19 Vaccines & Therapeutics Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan COVID-19 Vaccines & Therapeutics Sales Value, 2019-2030

6.6.2 Japan COVID-19 Vaccines & Therapeutics Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan COVID-19 Vaccines & Therapeutics Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea COVID-19 Vaccines & Therapeutics Sales Value, 2019-2030

6.7.2 South Korea COVID-19 Vaccines & Therapeutics Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea COVID-19 Vaccines & Therapeutics Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia COVID-19 Vaccines & Therapeutics Sales Value, 2019-2030

6.8.2 Southeast Asia COVID-19 Vaccines & Therapeutics Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia COVID-19 Vaccines & Therapeutics Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India COVID-19 Vaccines & Therapeutics Sales Value, 2019-2030

6.9.2 India COVID-19 Vaccines & Therapeutics Sales Value by Type (%), 2023 VS 2030

6.9.3 India COVID-19 Vaccines & Therapeutics Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Pfizer

7.1.1 Pfizer Profile

7.1.2 Pfizer Main Business

7.1.3 Pfizer COVID-19 Vaccines & Therapeutics Products, Services and Solutions

7.1.4 Pfizer COVID-19 Vaccines & Therapeutics Revenue (US$ Million) & (2019-2024)

7.1.5 Pfizer Recent Developments

7.2 Moderna Therapeutics

7.2.1 Moderna Therapeutics Profile

7.2.2 Moderna Therapeutics Main Business

7.2.3 Moderna Therapeutics COVID-19 Vaccines & Therapeutics Products, Services and Solutions

7.2.4 Moderna Therapeutics COVID-19 Vaccines & Therapeutics Revenue (US$ Million) & (2019-2024)

7.2.5 Moderna Therapeutics Recent Developments

7.3 AstraZeneca

7.3.1 AstraZeneca Profile

7.3.2 AstraZeneca Main Business

7.3.3 AstraZeneca COVID-19 Vaccines & Therapeutics Products, Services and Solutions

7.3.4 AstraZeneca COVID-19 Vaccines & Therapeutics Revenue (US$ Million) & (2019-2024)

7.3.5 Janssen Recent Developments

7.4 Janssen

7.4.1 Janssen Profile

7.4.2 Janssen Main Business

7.4.3 Janssen COVID-19 Vaccines & Therapeutics Products, Services and Solutions

7.4.4 Janssen COVID-19 Vaccines & Therapeutics Revenue (US$ Million) & (2019-2024)

7.4.5 Janssen Recent Developments

7.5 Novavax

7.5.1 Novavax Profile

7.5.2 Novavax Main Business

7.5.3 Novavax COVID-19 Vaccines & Therapeutics Products, Services and Solutions

7.5.4 Novavax COVID-19 Vaccines & Therapeutics Revenue (US$ Million) & (2019-2024)

7.5.5 Novavax Recent Developments

7.6 Gilead Sciences

7.6.1 Gilead Sciences Profile

7.6.2 Gilead Sciences Main Business

7.6.3 Gilead Sciences COVID-19 Vaccines & Therapeutics Products, Services and Solutions

7.6.4 Gilead Sciences COVID-19 Vaccines & Therapeutics Revenue (US$ Million) & (2019-2024)

7.6.5 Gilead Sciences Recent Developments

7.7 Eli Lilly and Company

7.7.1 Eli Lilly and Company Profile

7.7.2 Eli Lilly and Company Main Business

7.7.3 Eli Lilly and Company COVID-19 Vaccines & Therapeutics Products, Services and Solutions

7.7.4 Eli Lilly and Company COVID-19 Vaccines & Therapeutics Revenue (US$ Million) & (2019-2024)

7.7.5 Eli Lilly and Company Recent Developments

8 Industry Chain Analysis

8.1 COVID-19 Vaccines & Therapeutics Industrial Chain

8.2 COVID-19 Vaccines & Therapeutics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 COVID-19 Vaccines & Therapeutics Sales Model

8.5.2 Sales Channel

8.5.3 COVID-19 Vaccines & Therapeutics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Moderna Therapeutics

Astrazeneca plc

Janssen

Novavax Inc

Gilead Sciences

Eli Lilly and Company

List of Tables

Table 1. COVID-19 Vaccines & Therapeutics Market Trends

Table 2. COVID-19 Vaccines & Therapeutics Market Drivers & Opportunity

Table 3. COVID-19 Vaccines & Therapeutics Market Challenges

Table 4. COVID-19 Vaccines & Therapeutics Market Restraints

Table 5. Global COVID-19 Vaccines & Therapeutics Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global COVID-19 Vaccines & Therapeutics Revenue Market Share by Company (2019-2024)

Table 7. Key Companies COVID-19 Vaccines & Therapeutics Manufacturing Base Distribution and Headquarters

Table 8. Key Companies COVID-19 Vaccines & Therapeutics Product Type

Table 9. Key Companies Time to Begin Mass Production of COVID-19 Vaccines & Therapeutics

Table 10. Global COVID-19 Vaccines & Therapeutics Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Vaccines & Therapeutics as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global COVID-19 Vaccines & Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global COVID-19 Vaccines & Therapeutics Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global COVID-19 Vaccines & Therapeutics Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global COVID-19 Vaccines & Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global COVID-19 Vaccines & Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global COVID-19 Vaccines & Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global COVID-19 Vaccines & Therapeutics Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global COVID-19 Vaccines & Therapeutics Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global COVID-19 Vaccines & Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global COVID-19 Vaccines & Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global COVID-19 Vaccines & Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global COVID-19 Vaccines & Therapeutics Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global COVID-19 Vaccines & Therapeutics Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global COVID-19 Vaccines & Therapeutics Sales Value by Region (2019-2024) & (%)

Table 27. Global COVID-19 Vaccines & Therapeutics Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions COVID-19 Vaccines & Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions COVID-19 Vaccines & Therapeutics Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions COVID-19 Vaccines & Therapeutics Sales Value, (2025-2030) & (US$ Million)

Table 31. Pfizer Basic Information List

Table 32. Pfizer Description and Business Overview

Table 33. Pfizer COVID-19 Vaccines & Therapeutics Products, Services and Solutions

Table 34. Revenue (US$ Million) in COVID-19 Vaccines & Therapeutics Business of Pfizer (2019-2024)

Table 35. Pfizer Recent Developments

Table 36. Moderna Therapeutics Basic Information List

Table 37. Moderna Therapeutics Description and Business Overview

Table 38. Moderna Therapeutics COVID-19 Vaccines & Therapeutics Products, Services and Solutions

Table 39. Revenue (US$ Million) in COVID-19 Vaccines & Therapeutics Business of Moderna Therapeutics (2019-2024)

Table 40. Moderna Therapeutics Recent Developments

Table 41. AstraZeneca Basic Information List

Table 42. AstraZeneca Description and Business Overview

Table 43. AstraZeneca COVID-19 Vaccines & Therapeutics Products, Services and Solutions

Table 44. Revenue (US$ Million) in COVID-19 Vaccines & Therapeutics Business of AstraZeneca (2019-2024)

Table 45. AstraZeneca Recent Developments

Table 46. Janssen Basic Information List

Table 47. Janssen Description and Business Overview

Table 48. Janssen COVID-19 Vaccines & Therapeutics Products, Services and Solutions

Table 49. Revenue (US$ Million) in COVID-19 Vaccines & Therapeutics Business of Janssen (2019-2024)

Table 50. Janssen Recent Developments

Table 51. Novavax Basic Information List

Table 52. Novavax Description and Business Overview

Table 53. Novavax COVID-19 Vaccines & Therapeutics Products, Services and Solutions

Table 54. Revenue (US$ Million) in COVID-19 Vaccines & Therapeutics Business of Novavax (2019-2024)

Table 55. Novavax Recent Developments

Table 56. Gilead Sciences Basic Information List

Table 57. Gilead Sciences Description and Business Overview

Table 58. Gilead Sciences COVID-19 Vaccines & Therapeutics Products, Services and Solutions

Table 59. Revenue (US$ Million) in COVID-19 Vaccines & Therapeutics Business of Gilead Sciences (2019-2024)

Table 60. Gilead Sciences Recent Developments

Table 61. Eli Lilly and Company Basic Information List

Table 62. Eli Lilly and Company Description and Business Overview

Table 63. Eli Lilly and Company COVID-19 Vaccines & Therapeutics Products, Services and Solutions

Table 64. Revenue (US$ Million) in COVID-19 Vaccines & Therapeutics Business of Eli Lilly and Company (2019-2024)

Table 65. Eli Lilly and Company Recent Developments

Table 66. Key Raw Materials Lists

Table 67. Raw Materials Key Suppliers Lists

Table 68. COVID-19 Vaccines & Therapeutics Downstream Customers

Table 69. COVID-19 Vaccines & Therapeutics Distributors List

Table 70. Research Programs/Design for This Report

Table 71. Key Data Information from Secondary Sources

Table 72. Key Data Information from Primary Sources

Table 73. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. COVID-19 Vaccines & Therapeutics Product Picture

Figure 2. Global COVID-19 Vaccines & Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global COVID-19 Vaccines & Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 4. COVID-19 Vaccines & Therapeutics Report Years Considered

Figure 5. Global COVID-19 Vaccines & Therapeutics Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by COVID-19 Vaccines & Therapeutics Revenue in 2023

Figure 7. COVID-19 Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. COVID-19 Vaccines Picture

Figure 9. COVID-19 Therapeutics Picture

Figure 10. Global COVID-19 Vaccines & Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global COVID-19 Vaccines & Therapeutics Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Children

Figure 13. Product Picture of Adult

Figure 14. Global COVID-19 Vaccines & Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global COVID-19 Vaccines & Therapeutics Sales Value Market Share by Application, 2023 & 2030

Figure 16. North America COVID-19 Vaccines & Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 17. North America COVID-19 Vaccines & Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 18. Europe COVID-19 Vaccines & Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 19. Europe COVID-19 Vaccines & Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 20. Asia Pacific COVID-19 Vaccines & Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 21. Asia Pacific COVID-19 Vaccines & Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 22. South America COVID-19 Vaccines & Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 23. South America COVID-19 Vaccines & Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 24. Middle East & Africa COVID-19 Vaccines & Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 25. Middle East & Africa COVID-19 Vaccines & Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 26. Key Countries/Regions COVID-19 Vaccines & Therapeutics Sales Value (%), (2019-2030)

Figure 27. United States COVID-19 Vaccines & Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 28. United States COVID-19 Vaccines & Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 29. United States COVID-19 Vaccines & Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 30. Europe COVID-19 Vaccines & Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 31. Europe COVID-19 Vaccines & Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 32. Europe COVID-19 Vaccines & Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 33. China COVID-19 Vaccines & Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 34. China COVID-19 Vaccines & Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 35. China COVID-19 Vaccines & Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 36. Japan COVID-19 Vaccines & Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 37. Japan COVID-19 Vaccines & Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 38. Japan COVID-19 Vaccines & Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 39. South Korea COVID-19 Vaccines & Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 40. South Korea COVID-19 Vaccines & Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 41. South Korea COVID-19 Vaccines & Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 42. Southeast Asia COVID-19 Vaccines & Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 43. Southeast Asia COVID-19 Vaccines & Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 44. Southeast Asia COVID-19 Vaccines & Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 45. India COVID-19 Vaccines & Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 46. India COVID-19 Vaccines & Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 47. India COVID-19 Vaccines & Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 48. COVID-19 Vaccines & Therapeutics Industrial Chain

Figure 49. COVID-19 Vaccines & Therapeutics Manufacturing Cost Structure

Figure 50. Channels of Distribution (Direct Sales, and Distribution)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

COVID 19 RNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Covid 19 Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Clinical Treatment for Covid 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Covid 19 Vaccine Bottle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COVID 19 DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Coronavirus COVID 19 Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral COVID 19 Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COVID 19 Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Approved COVID 19 Vaccines Market Research Report 2025

COVID 19 Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Coronavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global COVID 19 Medicine Market Research Report 2024

COVID 19 Vaccine Transportation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Covid 19 Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vials for COVID 19 Vaccine Market Research Report 2024

Remdesivir COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Covid 19 Vaccine Market Research Report 2024

Covid 19 Vaccine Logistics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Coronavirus Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions